RNAZ

TransCode Therapeutics, Inc. Common Stock

7.92

USD

RNAZ Earnings Reports

Positive Surprise Ratio

RNAZ beat 5 of 11 last estimates.

45%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q-- -1 (Revenue/ EPS)

TransCode Therapeutics, Inc. Common Stock earnings per share and revenue

On --, RNAZ reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were TransCode Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?

For Q-- --, TransCode Therapeutics, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to TransCode Therapeutics, Inc. Common Stock's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is TransCode Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for TransCode Therapeutics, Inc. Common Stock's next earnings report?

Based on -- analysts, TransCode Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.